| Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases M Mehta, Deeksha, D Tewari, G Gupta, R Awasthi, H Singh, P Pandey, ... Chemico-Biological Interactions 308, 206-15, 2019 | 589 | 2019 |
| The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress K Dua, R Wadhwa, G Singhvi, V Rapalli, SD Shukla, MD Shastri, G Gupta, ... Drug development research 80 (6), 714-730, 2019 | 307 | 2019 |
| Lipid nanoparticles as carriers for bioactive delivery N Dhiman, R Awasthi, B Sharma, H Kharkwal, GT Kulkarni Frontiers in Chemistry 9, 580118, 2021 | 274 | 2021 |
| Gastroretentive dosage forms: A review with special emphasis on floating drug delivery systems VK Pawar, S Kansal, G Garg, R Awasthi, D Singodia, GT Kulkarni Drug delivery 18 (2), 97-110, 2011 | 271 | 2011 |
| Nanoparticles in cancer treatment: opportunities and obstacles R Awasthi, A Roseblade, PM Hansbro, MJ Rathbone, K Dua, M Bebawy Current drug targets 19 (14), 1696-1709, 2018 | 209 | 2018 |
| Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: An emerging need for novel drug delivery systems K Dua, V Malyla, G Singhvi, R Wadhwa, RV Krishna, SD Shukla, ... Chemico-biological interactions 299, 168-178, 2019 | 134 | 2019 |
| Phytosomes: An Approach to Increase The Bioavailability of Plant Extracts R Awasthi, GT Kulkarni, VK Pawar International Journal of Pharmacy and Pharmaceutical Sciences 3 (2), 1-3, 2011 | 114 | 2011 |
| Formation of struvite urinary stones and approaches towards the inhibition—A review P Das, G Gupta, V Velu, R Awasthi, K Dua, H Malipeddi Biomedicine & pharmacotherapy 96, 361-370, 2017 | 95 | 2017 |
| Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand? R Awasthi, GT Kulkarni Drug delivery 23 (2), 378-394, 2016 | 93 | 2016 |
| Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, characterization, in vitro and in vivo evaluation S Godara, V Lather, SV Kirthanashri, R Awasthi, D Pandita Materials Science and Engineering: C 109, 110576, 2020 | 78 | 2020 |
| Dual crosslinked pectin–alginate network as sustained release hydrophilic matrix for repaglinide R Awasthi, GT Kulkarni, MV Ramana, TJA Pinto, IS Kikuchi, DDM Ghisleni, ... International journal of biological macromolecules 97, 721-732, 2017 | 77 | 2017 |
| Berberine: a plant-derived alkaloid with therapeutic potential to combat Alzheimer’s disease AK Singh, SK Singh, MK Nandi, G Mishra, A Maurya, A Rai, GK Rai, ... Central Nervous System Agents in Medicinal Chemistry (Formerly Current …, 2019 | 76 | 2019 |
| Lipid-Coated MCM-41 Mesoporous Silica Nanoparticles Loaded with Berberine Improved Inhibition of Acetylcholine Esterase and Amyloid Formation AK Singh, SS Singh, AS Rathore, SP Singh, G Mishra, R Awasthi, ... ACS Biomaterials Science & Engineering, 2021 | 70 | 2021 |
| Targeting chronic inflammatory lung diseases using advanced drug delivery systems K Dua, PM Hansbro, R Wadhwa, M Haghi, LG Pont, KA Williams Academic Press, 2020 | 67 | 2020 |
| Chalcones: A review on synthesis and pharmacological activities K Goyal, R Kaur, A Goyal, R Awasthi Journal of Applied pharmaceutical science 11 (1), 001-014, 2021 | 64 | 2021 |
| Development of novel gastroretentive drug delivery system of gliclazide: Hollow beads R Awasthi, GT Kulkarni Drug development and industrial pharmacy 40 (3), 398-408, 2014 | 62 | 2014 |
| Therapeutic Potential of Phytoconstituents in Management of Alzheimer’s Disease AK Singh, SN Rai, A Maurya, G Mishra, R Awasthi, A Shakya, ... Evidence-Based Complementary and Alternative Medicine 2021, 2021 | 60 | 2021 |
| Molecular mechanisms of action of naringenin in chronic airway diseases LH Chin, CM Hon, DK Chellappan, J Chellian, T Madheswaran, ... European journal of pharmacology 879, 173139, 2020 | 59 | 2020 |
| Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast JR Madan, S Khobaragade, K Dua, R Awasthi Dermatologic therapy 33 (3), e13370, 2020 | 57 | 2020 |
| Solid lipid nanoparticles containing anti-tubercular drugs attenuate the Mycobacterium marinum infection S Khatak, M Mehta, R Awasthi, KR Paudel, SK Singh, M Gulati, ... Tuberculosis 125, 102008, 2020 | 55 | 2020 |
Kamal DuaAssociate Professorยืนยันอีเมลแล้วที่ uts.edu.au